Keyphrases
Heart Failure
100%
Heart Failure with Preserved Ejection Fraction (HFpEF)
85%
COVID-19
60%
Dapagliflozin
40%
Proteomics
40%
Intermittent Fasting
38%
Macrophages
36%
Adverse Outcomes
34%
Human Heart Failure
34%
Transcription Factor EB
30%
Prognostic Significance
30%
Hazard Ratio
30%
Patients with Heart Failure
29%
High-density Lipoprotein Cholesterol (HDL-C)
29%
DNA Damage
28%
Lipid Metabolism
27%
Rad9
26%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
24%
Placebo
23%
Apolipoprotein M
22%
Cardiovascular Risk
22%
Randomized Clinical Trial
22%
Cardiomyopathy
22%
Radiation Therapy
22%
Cardiac Allograft Vasculopathy
21%
DNA Damage Checkpoint
21%
Inflammation
21%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
20%
Cholesterol Efflux Capacity
20%
Doxorubicin
20%
Lysosome
20%
Autophagy
19%
G1 Checkpoint
17%
Chromatin
16%
TOPCAT
16%
Lipids
16%
Phosphorylation
16%
NuA4
16%
Myocytes
15%
Cardiac Function
15%
Growth Differentiation factor-15 (GDF-15)
15%
Double-strand Breaks
15%
Doxorubicin-induced Cardiotoxicity
14%
Cardiovascular Disease
13%
Type 1 Diabetes Mellitus (T1DM)
13%
Human Heart
13%
Sigma Phase
13%
Therapeutic Target
12%
Cardiomyocytes
12%
Randomized Controlled Trial
12%
Biochemistry, Genetics and Molecular Biology
Proteomics
81%
Heart Ejection Fraction
79%
DNA Damage
43%
Transcription Factors
36%
Autophagy
33%
Macrophage
30%
Cardiac Muscle Cell
29%
Lysosome
28%
Doxorubicin
27%
Blood Plasma
26%
N-Terminus
25%
Brain Natriuretic Peptide
25%
G1/S Transition
23%
Apolipoprotein
23%
Heart Function
21%
Clinical Trial
21%
DNA Damage Checkpoint
20%
Kinase
18%
Phosphotransferase
18%
High-Density Lipoprotein
18%
Lipid Metabolism
18%
Growth Differentiation Factor
17%
Cell Death
17%
Histone H2A
16%
Serum Total Protein
16%
Lipid
16%
Biogenesis
15%
Heart Left Ventricle Ejection Fraction
14%
DNA Repair
14%
Histone H3
13%
Chromatin Remodeling
13%
Glomerulus Filtration
13%
S Phase
13%
Proteome
12%
Genetics
12%
Sphingosine-1-Phosphate
12%
Mechanistic Target of Rapamycin
12%
HDL-Cholesterol
12%
Ubiquitin
11%
Secretion (Process)
11%
Methylation
11%
Serine
11%
Aldosterone
10%
Stem Cell
10%
Enzyme
10%
Cluster of Differentiation
10%
Apolipoprotein B
10%
Hepatocyte
10%
Oxidoreductase
10%
RNA Sequence
10%
Medicine and Dentistry
Congestive Heart Failure
95%
Proteomics
43%
COVID-19
40%
Heart Failure with Preserved Ejection Fraction
33%
Intermittent Fasting
31%
Dapagliflozin
30%
Cardiovascular System
28%
Radiation Therapy
28%
Lysosome
27%
Placebo
26%
Adverse Outcome
23%
Macrophage
21%
Heart Graft
21%
Cardiac Allograft Vasculopathy
20%
Cardiovascular Risk
20%
Effusion
20%
High-Density Lipoprotein
20%
Hazard Ratio
18%
Cardiotoxicity
16%
Autophagy
15%
Transplantation
15%
Diabetes Mellitus
14%
Diseases
13%
Transcription Factors
13%
Myocardial Disease
13%
Cardiovascular Disease
13%
Lipid Metabolism
13%
Apolipoprotein M
12%
Heart Failure with Reduced Ejection Fraction
12%
Nutrient Sensing
12%
Mechanistic Target of Rapamycin
12%
Diabetes
12%
Heart Function
11%
Cardiometabolic Risk
11%
Randomized Clinical Trial
11%
Kidney Injury
11%
Fibroblast
10%
Sodium Glucose Cotransporter 2 Inhibitor
10%
Leucine
10%
Respiratory Failure
10%
Isoproterenol-Induced Cardiac Hypertrophy
10%
Hemophagocytic Lymphohistiocytosis Syndrome
10%
Refeeding
10%
Cellular Infiltration
10%
Head and Neck Cancer
10%
Ionizing Radiation
10%
Risk Evaluation
10%
Peripartum Cardiomyopathy
10%
Allograft Vasculopathy
10%
angiotensin[1-7]
10%
